?Cancer Research Career Enhancement The Mays Cancer Center (MCC) Cancer Research Career Enhancement (CRCE) Core seeks to provide a continuous supply of well-trained cancer scientists performing state-of-the-art cancer research. The Core is led by Robin Leach, Ph.D., (PSP) Associate Director (AD) for Education and a member of the Cancer Center since its inception. The UT Health San Antonio (UT Health SA) is the largest academic Health Science Center for South Texas and includes Schools of Medicine, Nursing, Dentistry, Health Professions, and the Graduate School of Biomedical Sciences. The UT Health SA is designated by the U.S. Department of Education as a Hispanic- serving Institution and consistently ranks as one of the top schools in the U.S. for graduating Hispanic health care providers. The MCC at the UT Health SA places a high priority on education and mentoring, and does so both within the Cancer Center and by integrating and coordinating activities with existing programs at UT Health SA. The MCC has dedicated resources to cancer-related training and career development from high schoolers through early- stage faculty levels. During the last reporting period, the MCC has provided cancer research training for 51 high school students and 155 undergraduates in summer enrichment and training programs. MCC members have trained 115 M.S. and 147 Ph.D. level graduate students, 30 medical students (via an accredited medical school research electives course), 25 M.D./Ph.D. students, and 2 D.D.S./Ph.D. students. A total of 70 physicians have completed MCC?s fellowships in Hematology and Medical Oncology, Advanced Oncology Drug Development, Urologic Oncology and Pediatric Hematology-Oncology. In new activities, the CRCE Core has established an Office of Education at the MCC, revitalized an advisory MCC Education Committee, and established an Affiliate membership category for trainees. Importantly, the CRCE Core has augmented cancer-related research mentoring for early-stage faculty who are Associate Members of MCC, partnering the basic scientists with senior clinical faculty and the clinical scientists with senior basic science faculty. During the upcoming funding period, the Core will continue summer training in cancer research for high school through college students, and develop new training opportunities for middle school students. Importantly, most of these efforts will target opportunities for underrepresented populations. We will also leverage and expand the existing cancer-related education and training activities throughout UT Health SA. We will continue to support mentoring and career development among advanced trainees ? from fellows through early-stage faculty ? with an emphasis on fostering participation of underserved minorities to produce a more diverse cancer research workforce of the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-25
Application #
10025086
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-08-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Yu, Xiaojie; Zhang, Yiqiang; Cavazos, David et al. (2018) miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer. Cell Death Dis 9:193
Chen, Chen; Zhao, Shujie; Karnad, Anand et al. (2018) The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol 11:64
Abbott, Jamie A; Meyer-Schuman, Rebecca; Lupo, Vincenzo et al. (2018) Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy. Hum Mutat 39:415-432
Guo, Jiayan; Kim, Hong Seok; Asmis, Reto et al. (2018) Interactions of ? tubulin isotypes with glutathione in differentiated neuroblastoma cells subject to oxidative stress. Cytoskeleton (Hoboken) 75:283-289
Liss, Michael A; Chen, Yidong; Rodriguez, Ronald et al. (2018) Immunogenic Heterogeneity of Renal Cell Carcinoma With Venous Tumor Thrombus. Urology :
Zhu, Haiyan; Xia, Lu; Shen, Qi et al. (2018) Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Lab Invest 98:1384-1396
Zeno, Wade F; Baul, Upayan; Snead, Wilton T et al. (2018) Synergy between intrinsically disordered domains and structured proteins amplifies membrane curvature sensing. Nat Commun 9:4152
Mahalingam, Devalingam; Goel, Sanjay; Aparo, Santiago et al. (2018) A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma. Cancers (Basel) 10:
Yu, Xiaojie; Zhang, Yiqiang; Ma, Xiuye et al. (2018) miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. Cancer Lett 427:85-93
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :

Showing the most recent 10 out of 989 publications